Shots: The approval is based on results from pre-registration clinical programme assessing Esperoct in 270 patients with severe hemophilia A with 5+years of clinical exposure. The authorization covers all 28 […]readmore
Tags : N8-GP
Shots: The positive opinion is based on largest pre-registration clinical programme assessing Esperoct (FD, IV, q4days) in 270 patients previously treated with severe hemophilia A and more than 5 years […]readmore
Shots: The BLA approval is based on the trial assessing Esperoct (turoctocog alfa pegol, N8-GP) in 270 patients with previously treated people (PTPs) with severe haemophilia A The study resulted […]readmore